-dipine
A calcium channel blocker of the dihydropyridine kind, like nifedipine and amlodipine: relaxes blood vessels.
- Drugs ending in -dipine: 19
- Approved somewhere: 12
- With a US drug page: 8
- Stem
- -dipine
- Class
- Dihydropyridine calcium channel blockers like nifedipine
- Most common targets
- Voltage-gated L-type calcium channel (18), NR3C2 (2)
Approved and clinical-stage drugs in ChEMBL whose names ending in -dipine, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Clevidipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Felodipine | Approved | NR3C2, Voltage-gated L-type calcium channel | Mineralocorticoid receptor antagonist |
| Isradipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Levamlodipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Nicardipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Nifedipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Nimodipine | Approved | NR3C2, Voltage-gated L-type calcium channel | Mineralocorticoid receptor antagonist |
| Nisoldipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Amlodipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Lacidipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Lercanidipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Nitrendipine | Approved | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Benidipine | Phase 3 | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Cilnidipine | Phase 3 | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Manidipine 6300 | Phase 3 | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Nilvadipine | Phase 3 | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Barnidipine | Phase 2 | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
| Budipine | Phase 2 | โ | โ |
| Azelnidipine | โ | Voltage-gated L-type calcium channel | Voltage-gated L-type calcium channel blocker |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO